STREAM (Standardised Treatment Regimens of Anti-tuberculosis drugs for Multidrug-Resistant Tuberculosis) Stage 1 demonstrated non-inferior efficacy of a short regimen for rifampicin-resistant TB (RR-TB) compared to a long regimen as recommended by the World Health Organization. This study analyzed factors associated with a definite or probable failure or relapse (FoR) event in participants receiving the short regimen. The factors associated with FoR outcomes identified in this study should be considered when determining the optimal shortened treatment regimen.
Published: August 1, 2022
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Recent Abstracts
Lessons from Vietnam’s Campaign for a Tax on Sugar-Sweetened Beverages
Principles of Alcohol Taxation
Clean Air in Jakarta: Gaps and Possibilities Toward Low Emission Practices
Public Attitudes Towards Alcohol Policy: South Africa
Quality Assurance and Improvement Framework for Medical Certification of Cause of Death and…
More Data Better Health: Climate and Health in the Legal Amazon
Mais Dados Mais Saúde: Clima e Saúde na Amazônia Legal
Health Taxes Action Guide
Opinión pública frente a la política de alcohol: Colombia
Public Attitudes Towards Alcohol Policy: Colombia